New Millennium Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.14K Sell
103
-1
-1% -$78 ﹤0.01% 216
2025
Q3
$8.31K Hold
104
﹤0.01% 232
2025
Q2
$9.45K Hold
104
0.01% 202
2025
Q1
$9.74K Sell
104
-6
-5% -$537 0.01% 206
2024
Q4
$10K Buy
110
+6
+6% +$573 0.01% 223
2024
Q3
$10.8K Hold
104
0.01% 179
2024
Q2
$10.1K Buy
+104
New +$9.59K 0.01% 188
2024
Q1
Sell
-104
Closed -$8.29K 127
2023
Q4
$8.29K Hold
104
0.01% 212
2023
Q3
$7.39K Hold
104
0.01% 186
2023
Q2
$8.01K Hold
104
0.01% 185
2023
Q1
$7.82K Hold
104
0.01% 206
2022
Q4
$8.19K Hold
104
0.01% 210
2022
Q3
$7K Hold
104
0.01% 212
2022
Q2
$8K Buy
+104
New +$8.13K 0.01% 204

Other funds holding CL

New Millennium Group's CL Position: Q4 2025 in Review

New Millennium Group reduced its Colgate-Palmolive (CL) stake by 0.96% in Q4 2025, selling an estimated $78 and leaving 103 shares worth $8.14K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

New Millennium Group first reported a position in CL in Q2 2022 and has held it in 14 quarters since. The position peaked at $10.8K in Q3 2024. 1,887 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • New Millennium Group held 103 shares of Colgate-Palmolive worth $8.14K as of Q4 2025.
  • New Millennium Group sold 1 Colgate-Palmolive share in Q4 2025, an estimated $78.
  • Colgate-Palmolive made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #216 holding.
  • New Millennium Group first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 14 quarters since.
  • New Millennium Group's Colgate-Palmolive position peaked at $10.8K in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.